Journal article
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn’s Disease: 2025 AGA Evidence Synthesis
Abstract
BACKGROUND & AIMS: We performed an updated systematic review and network meta-analysis to inform the 2025 American Gastroenterological Association Clinical Guidelines on the management of moderate-to-severe Crohn's disease (CD).
METHODS: We searched multiple electronic databases from inception through August 14, 2024, to identify randomized controlled trials in adults with moderate-to-severe CD, comparing advanced therapies (eg, tumor necrosis …
Authors
Singh S; Murad MH; Yuan Y; Ananthakrishnan AN; Click B; Syal G; Haydek JP; Agrawal M; Kappelman MD; Lewis JD
Journal
Gastroenterology, Vol. 169, No. 7, pp. 1516–1536
Publisher
Elsevier
Publication Date
12 2025
DOI
10.1053/j.gastro.2025.08.032
ISSN
0016-5085
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
HumansCrohn DiseaseSeverity of Illness IndexTreatment OutcomeRemission InductionRandomized Controlled Trials as TopicGastrointestinal AgentsNetwork Meta-Analysis as TopicTumor Necrosis Factor InhibitorsAntibodies, Monoclonal, HumanizedPractice Guidelines as TopicMaintenance ChemotherapyInduction ChemotherapyJanus Kinase InhibitorsUstekinumab